Viewing nowAmaphil Tablet (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

MFDS item code 200402913 · Notified 2004.09.23 · Insurance code 661900810
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used as a therapeutic agent to complement dietary and exercise therapy for the improvement of blood sugar control in patients with type 2 diabetes. It can be administered alone and can also be used in combination with insulin or other oral hypoglycemic agents when blood sugar control is inadequate. In particular, it helps improve blood sugar control when monotherapy with sulfonylurea or metformin is ineffective. This medication effectively improves blood sugar control in patients with type 2 diabetes.
Adjust the dose individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. This medicine is administered orally once a day. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once a day. If needed, increase the dose by 1 mg at intervals of 1–2 weeks. In general, there is little additional benefit with doses above 4 mg, but some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg a day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start treatment with 1 mg once a day and adjust the dose at intervals of 1–2 weeks. The potency and duration of action of the previously administered medicine should be considered. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once a day with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the doses of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication is not to be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a state of coma. Patients who have had allergic reactions to this medication or sulfonylureas, as well as those with severe liver or kidney dysfunction, should also avoid taking this medication. Women who are pregnant or may become pregnant, and nursing mothers should not use this medication. In cases of severe infections, before and after surgery, and for patients with major trauma, insulin treatment is recommended, and this medication should be avoided. In cases of gastrointestinal disorders such as diarrhea or vomiting, caution is required, as impaired food absorption may pose a risk of hypoglycemia. During the first week of taking this medication, the risk of hypoglycemia is high, so blood sugar levels should be monitored closely. Particularly, elderly patients, those with poor nutritional status or irregular eating habits, patients with weakened kidney or liver function, and those having other endocrine disorders should be extra careful. Additionally, individuals who frequently consume alcohol or take certain medications together might have an increased risk of hypoglycemia, so they should consult their healthcare provider. Symptoms of hypoglycemia may include headaches, severe hunger, nausea, fatigue, confusion, decreased consciousness, etc., and if such symptoms occur, immediate sugar intake or consultation with a healthcare provider is necessary. This medication may cause various side effects, including liver dysfunction, blood abnormalities, and allergic reactions; therefore, any unusual symptoms should be reported to a doctor immediately. When taking this medication for blood sugar control, dietary and exercise therapy should also be practiced, and it is important to take the medication regularly. If hypoglycemia occurs, consuming sugar or sugary drinks immediately is effective, while artificial sweeteners do not help. During treatment, patients should inform any doctors or pharmacists they meet of the current medications being taken and their diabetes status, and in stressful situations such as trauma, surgery, or infections, insulin treatment may need to be switched to. This medication is excreted through the kidneys, so dosage adjustment is necessary for elderly patients with weakened kidney function. In case of overdose, hypoglycemic shock may occur, so immediate medical attention is required.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. Additionally, it is recommended to store it at room temperature between 1 degree Celsius and 30 degrees Celsius.
Green rectangular tablets
30 tablets/bottle - 30 tablets/bottle, 300 tablets/bottle - 300 tablets/bottle, export - 30 tablets/PTP - 30 tablets/PTP [for export]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.